Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPMAT study of liposomal prednisolone for radiocephalic fistula maturation
NL-OMON44992Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2016
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal prednisolone in end-stage kidney disease (ESKD), dialysis access dysfunction (VAF), sponsored by Leiden University Medical Center. Started Apr 2016; status: active, not recruiting.
02
Drugs
liposomal prednisolone
03
Conditions
end-stage kidney disease (ESKD)dialysis access dysfunction (VAF)
Beyond the preview
Go deeper on NL-OMON44992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44992.